The Parkinson disease (PD) genetic LRRK2 gain-of-function mutations may relate to the ER pathological changes seen in PD patients at postmortem. Human induced pluripotent stem cell (iPSC)-derived neurons with the PD pathogenic LRRK2 G2019S mutation exhibited neurite collapse when challenged with the ER Ca 2+ influx sarco/ER Ca 2+ -ATPase inhibitor thapsigargin (THP 
INTRODUCTION
The leucine-rich repeat kinase 2 (LRRK2) G2019S gain-offunction mutation, which increases LRRK2 kinase activity (Islam and Moore, 2017; West et al., 2005) , is one of the most prevalent autosomal dominant mutations contributing to Parkinson disease (PD) pathogenesis with variable penetrance. Genetic variations in the LRRK2 locus are also associated with an increased risk for sporadic PD development (Nalls et al., 2014) . The G2019S-dependent increase in kinase activity is implicated in organelle mechanisms such as mitochondrial function, transport, and mobility (Cooper et al., 2012; Sanders et al., 2014; Smith et al., 2016) ; neurite outgrowth (Reinhardt et al., 2013; Sanchez-Danes et al., 2012) ; endosomal and vesicle transport (Rivero-Rios et al., 2015; Steger et al., 2016) ; autophagy (Schapansky et al., 2014) and Ca 2+ -dependent autophagosome formation (Gomez-Suaga et al., 2012) ; mitophagy (Hsieh et al., 2016) ; and calcium homeostasis (Bedford et al., 2016; Cherra et al., 2013; Schwab and Ebert, 2015; Verma et al., 2017; Yan et al., 2015) . However, the molecular mechanisms that link these multiple cellular functions with the LRRK2 G2019S mutation are not well understood. Calcium signaling controls cellular processes such as exocytosis, synaptic plasticity, gene transcription, oxidative phosphorylation, and organelle function (Sano and Reed, 2013) . Alterations in the intracellular Ca 2+ homeostasis are linked to neurodegeneration in PD (Guzman et al., 2010; Hurley et al., 2013) . The ER lumen is a major intracellular Ca 2+ storage facility (Lam and Galione, 2013) , with Ca 2+ -binding chaperones mediating protein folding. Given that the ER network extends throughout the cell and forms junctions with other cellular organelles such as mitochondria, plasma membrane, and lysosomes, which is crucial for coordinating and integrating intracellular Ca 2+ signals necessary for organelle communication and function (Lam and Galione, 2013; Wu et al., 2017) , we investigated how LRRK2 G2019S mutations associated with PD influence ER calcium control. Importantly, ER Ca 2+ fluctuations may have an impact on protein-folding capacity and contribute to ER stress (Sano and Reed, 2013) . Increased expression of ER stress markers is found in postmortem human PD brain tissue (Hoozemans et al., 2007) , and based on a meta-analysis of multiple genomewide association studies, the ER stress response appears to be a contributor to the development of PD pathology (Klemann et al., 2017) .
To understand the role of ER calcium regulation in LRRK2-dependent cellular function, we used PD patient stem cellderived neurons to examine intracellular and ER-specific calcium homeostasis and effects of ER calcium inhibition on neuronal function. Employing both LRRK2-targeted gene correction and antisense oligonucleotide (ASO) technology, we set out to determine the direct role of LRRK2 protein function in ER calcium control.
RESULTS

Inhibition of ER Ca 2+ Influx Induces Neurite Collapse in PD Patient iPSC-Derived LRRK2 G2019S Neurons
Given that ER stress plays a role in PD pathology (Hoozemans et al., 2007; Klemann et al., 2017) , with ER Ca 2+ fluctuations influencing the protein folding capacity of ER chaperones and contributing to ER stress (Sano and Reed, 2013) , we decided to determine if ER inhibition of Ca 2+ influx by thapsigargin (THP) would have a differential effect on neuronal vulnerability in established long-term human neuronal cultures derived from PD patients carrying the LRRK2 G2019S mutation. Upon the induction of ER stress with THP, the LRRK2 G2019S mutation did not change the expression regulation of the key ER stress response genes or the XBP1 splicing ( Figure S1 ). The LRRK2 G2019S mutation decreased the speed of axonal outgrowth in vitro in PD patient induced pluripotent stem cell (iPSC)-derived neurons shortly after plating (Figure 1 ), confirming the basic observation of decreased neurite length in previous reports (Reinhardt et al., 2013) . Furthermore, live cell imaging showed that neurite length stabilized over time in culture.
To study the role of ER Ca 2+ on neurite outgrowth, sarco/ER Ca 2+ -ATPase (Serca) inhibition was performed by THP treatment on the iPSC-derived neurons at 1 week of culture. Neurite length was significantly decreased in LRRK2 G2019S iPSC-derived neurons treated with 10 and 100 nM THP ( Figure 2A , 10 nM, p = 0.0214, F (1.01, 2.04) = 43.27; 100 nM, p = 0.035, F (1.13, 2.26) = 21.1). This effect was not observed in healthy subject (HS) control iPSC-derived neurons ( Figure 2B , 10 nM, p = 0.0586, F (1,2) = 15.58; 100 nM, p = 0.1183, F (1, 2) = 6.969) and, when replicated in an independent experiment, it was rescued by LRRK2 exon 41-specific ASO application ( Figure 2C , 10 nM, p = 0.0175, F (2, 6) = 8.563; 100 nM, p = 0.0063, F (2, 6) = 13.26; and Figure 2D , 10 nM, p = 0.1582, F (2, 6) = 2.546; 100 nM, p = 0.6274, F (2, 6) = 0.5043; only ASO-transfected (ASO+) cells selected for analysis), designed to instigate LRRK2 pre-mRNA exon 41 skipping containing the G2019S mutation. Exon 41 ASO treatment induced 60% of exon 41 skipping ( Figures S2A and S2B ) and reduced the LRRK2 protein level by 27% ( Figure S2C ). ASO transfection efficiency varied from 30% to 90% between experiments and between different neuronal iPSC-derived lines. Ex41 ASO had no effect on the neurite outgrowth in the HS iPSCderived neurons ( Figures S3A and S3B ). The SERCA inhibition-dependent axonal collapse was further confirmed in an additional independent set of PD patient iPSC-derived neurons carrying the G2019S mutation ( Figure 2E , 10 nM, p = 0.0004, F (1.02, 3.08) = 297; 100 nM, p = 0.0002, F (1.50, 4.52) = 106.1), and rescued by isogenic gene correction of the G2019S mutation by gene editing ( Figure 2F , 10 nM, p = 0.2665, F (1.29, 3.86) = 1.785; 100 nM, p = 0.088, F (1.20, 3.60) = 5.341). Finally, LRRK2 G2019S neurons were exposed to LRRK2 kinase inhibitor MLi-2 (Fell et al., 2015) , which consequently rescued neurite collapse induced by low-dose 10 nM THP treatment ( Figure 2G , vehicle, p = 0.0417, F statistic 6.5; 10 nM MLi-2, p = 0.1776, F (2, 6) = 2.337; 100 nM MLi-2, p = 0.4306, Friedman statistic 2). A lower THP concentration (1 nM) or vehicle treatment (EtOH) did not induce any changes Figure 1 . Neurite Outgrowth Is Initially Decreased in Human iPSC-Derived Neurons Carrying the LRRK2 G2019S Mutation (A) Shortly after plating, the speed of neurite outgrowth is significantly decreased in the human iPSC-derived neurons carrying the LRRK2 G2019S mutation (LRRK2; N = 3 independent PD patient lines: 29F, 9A, PD28 clone 1) compared with the healthy subject (HS; N = 3 independent HS lines 10A, 21.31, and 21.35) control neurons (p = 0.0018, F (1,32) = 11.55). (B) Similarly, when using a new cohort of PD patient iPSC-derived neurons, neurite outgrowth is initially decreased in LRRK2 neurons (N = 4 [N = 2 independent PD patient lines with 2 clones per line: IM1Mut -L2-1Mut, IM2Mut-L2-2Mut, T4.6(Mut)-L1-1Mut, T4.13(Mut)-L1-2Mut, see Table S1 ]) compared with their gene-corrected (GC) isogenic controls (p < 0.0001, F (1,36) = 62.76, N = 4 [N = 2 independent GC lines with 2 clones per line: IM1GC-L2-1GC, IM2GC-L2-2GC, T4.6.43(GC)-L1-1GC2, T4.13.10(GC)-L1-2GC, see Table S1 ]). Within 24 hr these outgrowth differences are no longer observed, as the neurites stabilize their networks. Each cell line represents a pool of 3 wells as technical replicates. Statistical analysis was performed using two-way ANOVA with Sidak's multiple testing correction (MTC). *p < 0.05, **p < 0.01. Error bars represent SEM. Table 1 ]) also showed neurite collapse after THP-induced Serca inhibition (10 nM, p = 0.0004, F (1.02, 3.08) = 297; 100 nM, p = 0.0002, F (1.50,4.52) = 106.1). Only ASO+ cells were used for the analysis. (F) The isogenic GC control neurons, pairs to LRRK2 neurons from (E) (Reinhardt et al., 2013) (N = 4 [N = 2 independent GC lines with 2 clones per line: IM1GC-L2-1GC, IM2GC-L2-2GC, T4.6.43(GC)-L1-1GC2, T4.13.10(GC)-L1-2GC, see Table S1 ]), do not show neurite collapse after THP treatment (10 nM, p = 0.2665, F (1.29, 3.86) = 1.785; 100 nM, p = 0.0880, F (1.20, 3.60) = 5.341). (G) In an independent experiment, LRRK2 kinase inhibitor MLi-2 rescued neurite collapse induced by 10 nM THP treatment in LRRK2 neurons (DMSO, p = 0.0417, Friedman statistic 6.5; 10 nM MLi-2, p = 0.1776, F (2, 6) = 2.337; 100 nM MLi-2, p = 0.4306, Friedman statistic 2). (H) MLi-2 kinase inhibition does not affect neurite collapse after a high-dose 100 nM THP treatment (DMSO, p = 0.0052, F (2, 6) = 14.29; 10 nM MLi-2, p = 0.0081, F (2, 6) = 11.91; 100 nM MLi-2, p = 0.0096, F (2, 6) = 11.13). For (G) and (H) the same set of PD patient lines was used as in (E) influx, compared with HS control neurons (p = 0.0448, t = 2.661, df = 5) ( Figure 3A ). Unbound intracellular Ca 2+ levels were significantly increased upon prolonged KCl membrane depolarization (p = 0.0303, t = 2.993, df = 5), indicating a decreased cellular capacity for intracellular Ca 2+ buffering in LRRK2 G2019S neurons ( Figure 3A ). This phenotype was diminished by treatment of LRRK2 neurons with an ASO targeting the LRRK2 exon 41 sequence (ex41 ASO, Figure 3B , second KCl stimulation, p = 0.458, t = 0.8039, df = 5, and the unbound Ca 2+ levels, p = 0.2878, t = 1.189, df = 5; only ASO+ cells selected for analysis). Ex41 ASO increased intracellular Ca 2+ levels (p = 0.0158, t = 7.851, df = 2) and decreased Ca 2+ buffering (p = 0.0246, t = 6.261, df = 2) in the HS iPSC-derived neurons when treated with THP ( Figures S3C-S3F ). Ca 2+ levels were equal in HS and LRRK2 G2019S neurons upon Serca inhibition when treated with ex41 ASO. Interestingly, no differences were observed in Ca 2+ uptake or Ca 2+ buffering between vehicle-treated HS and LRRK2 G2019S neurons ( Figure 3C , p = 0.7611, t = 0.3212, df = 5 and p = 0.4813, t = 0.7605, df = 5, respectively). These results show that LRRK2 mutation can modulate neuronal ER calcium homeostasis.
ER Ca 2+ Levels and Gene Expression of Key ER Ca
2+
Regulators Are Decreased in Human iPSC-Derived Neurons Carrying the LRRK2 G2019S Mutation To determine how LRRK2 contributes to ER calcium homeostasis, we first performed an ER-specific Ca 2+ level analysis in LRRK2 G2019S iPSC-derived neurons using an ER-specific Ca 2+ -measuring organelle-entrapped protein indicator, CEPIA1-ER GFP (Suzuki et al., 2014) . The specificity of the ER Ca 2+ detection was confirmed by a decrease in GFP levels in CEPIA-overexpressing neurons following Serca ER Ca 2+ influx inhibition with THP ( Figure S4 ). PD patient iPSC-derived LRRK2 G2019S neurons showed lower ER Ca 2+ levels compared with the HS control iPSC neurons, based on the total CEPIA1-ER GFP intensity ( Figure 4A , p = 0.0349, t = 2.871, df = 5). This phenotype was confirmed in an independent experiment with additional HS and PD iPSC lines, where the iPSC-derived neurons were transfected with the non-target Ctrl ASO ( Figure 4B , p = 0.0425, F (2, 12) = 4.155). The ER Ca 2+ deficiency was rescued by treating the PD patient neurons carrying the G2019S mutation with LRRK2 exon 41-specific ASO ( Figure 4B , p = 0.0425, F (2, 12) = 4.155, only ASO+ cells selected for analysis). A reduction in baseline ER Ca 2+ was also observed in midbrain dopamine (DA) iPSC-derived neurons carrying the LRRK2 G2019S mutation ( Figure 4C , p < 0.0001, K-W statistic 57.32), with ER Ca 2+ levels increased by treatment with LRRK2 ex41 ASO ( Figure 4C , only ASO+ cells selected for analysis). See Figure S2D for ex41 ASO treatmentinduced effects in midbrain DA neurons. Ex41 ASO treatment showed a non-significant trend to decrease ER Ca 2+ levels in the HS iPSC-derived neurons (Figures S3G and S3H) . Next, mRNA transcript expression levels of key molecules regulating ER Ca 2+ uptake, maintenance, and release were measured in iPSC-derived neurons carrying the LRRK2 G2019S mutation and compared with their isogenic gene-corrected controls (Table 1) . We found a significant 46% decrease in the expression of the ER Ca 2+ sensor STIM1 (p = 0.005, t = 4.316, df = 6), a 40% decrease in membrane receptor TRPC1 (p = 0.0209, t = 3.107, df = 6), and a 23% decrease in the Ca 2+ release-activated Ca 2+ membrane channel ORAI1 (p = 0.0038, t = 4.571, df = 6) in the LRRK2 G2019S iPSC neurons compared with their isogenic controls. These three molecules are critical for cellular store-operated Ca 2+ entry (SOCE). No significant changes were found in the expression of Serca isoforms 2 and 3 (SERCA2, p = 0.0875, t = 2.04, df = 6; SERCA3, p = 0.6254, t = 0.5144, df = 6), both known to be expressed in the brain (Wu et al., 1995) . In addition, there were no significant differences observed in the expression of ER Ca 2+ efflux ITP receptors (ITPR) 1 and 3, or of ryanodine receptors (RYR) 2 and 3 ( influx-activated signaling molecule, as a candidate interactor with the LRRK2 protein (Beilina et al., 2014) . CamK1D expression levels were found to be 69% decreased in iPSC-derived neurons carrying the LRRK2 G2019S mutation (Table 1 , p = 0.0150, t = 3.373, df = 6). Treatment of GD mice with the RyR antagonist dantrolene improved behavior and survival of these animals (Liou et al., 2016) . In vivo mouse models of two other lipid storage disorders, Sandhoff disease and Niemann-Pick A disease, are both characterized by neurodegenerative phenotypes and show decreases in Serca activity (Pelled et al., 2003) or both Serca and inositol trisphosphate receptor 3 (IP3R) expression levels (Ginzburg and Futerman, 2005) . Our findings of the LRRK2 G2019S mutation in human neurons producing decreased ER Ca 2+ levels and increased neurite collapse after Serca inhibition further point to the importance of this system in neuronal vulnerability.
Neuronal Vulnerability and Calcium Control
Previous work has shown that the LRRK2 G2019S mutation increases cellular vulnerability in human PD patient fibroblasts (Smith et al., 2016) and iPSC-derived neurons (Cooper et al., 2012) when exposed to mitochondrial stressors. We now find that the LRRK2 G2019S mutation, known to induce an increase in LRRK2 kinase activity (Islam and Moore, 2017; West et al., 2005) , plays a role in axonal vulnerability and modifies ER calcium control, potentially contributing to PD pathology (see schematic Figure 5 ). The LRRK2 G2019S mutation influences axonal integrity (Reinhardt et al., 2013; Sanchez-Danes et al., 2012; Winner (D) and (E) CEPIA-ER GFP levels were additionally normalized to the resting state (15-55 s) of each cell to detect the individual changes in ER Ca 2+ levels upon Ca 2+ efflux (DF). In each experiment, each line represents a pool of 3 technical replicates. Statistical analysis was performed using Student's two-tailed t test, one-way ANOVA with Holm-Sidak MTC, or Kruskal-Wallis test with Dunn's MTC. *p < 0.05, ****p < 0.0001. In (C) outliers were identified using the ROUT method with 1% default Q value. Error bars represent SEM. See also Figures S2-S4 . Beilina et al., 2014) Statistical analysis was performed using two-tailed unpaired Student's t test, p < 0.05. et al., 2011) in a kinase activity-dependent manner (Sheng et al., 2012) , with the current data presenting a specific kinase LRRK2 G2019S-dependent neurite collapse upon THP-induced SERCA inhibition, indicating a prominence of axonal vulnerability to alterations in ER Ca 2+ levels. Indeed, these human iPSC-derived neurons show decreased ER Ca 2+ levels already at baseline, possibly explained by reduced functionality of SOCE as a consequence of the decreased SOCE-related gene expression levels of STIM1, TRPC1, and ORA1. Corroborating this hypothesis, no changes were observed in the kinetics of CICR and ER Ca 2+ efflux receptor expression.
An impact of ER Ca 2+ levels on neurite outgrowth was seen in a hereditary model of spastic paraplegia induced by atlastin mutations, a neurodegenerative disorder characterized by a progressive gait disorder. In PC-12 cells, atlastin mutations inhibit nerve growth factor-stimulated neurite outgrowth by altering ER morphology and SOCE function through decreased STIM1 and ORA1 activation upon ER Ca 2+ depletion (Li et al., 2017) . Ca 2+ release from intra-axonal ER Ca 2+ stores contributes to secondary degradation of axons after spinal cord injury (Stirling et al., 2014) . The current findings of reduced TRPC1 expression in human LRRK2 G2019S neurons are interesting in this context, as surface membrane expression of TRPC1, a Ca 2+ channel activated upon SOCE initiation, is essential for neurite outgrowth and axon guidance in vitro (Heo et al., 2012; Kerstein et al., 2013) . Furthermore, inhibition of Cav1.3 channels through TRPC1-STIM1 complex influences DA neuron survival (Sun et al., 2017) . Compromised ER calcium control in LRRK2 G2019S neurons could contribute to increased neuronal vulnerability. Indeed, after Serca inhibition, there was an extensive neurite collapse, increased Ca 2+ uptake, and decreased intracellular Ca 2+ buffering, indicating cellular dysfunction as a consequence of the alterations in ER Ca 2+ regulation ( Figure 5 ).
Changes in ER Ca 2+ Levels May Influence Cell
Organelle Function ER Ca 2+ levels and ER Ca 2+ trafficking can affect ER function such as ER chaperone protein folding capacity, ER stress response, ER-driven lipid synthesis, ER stress-induced autophagy, transcription regulation, and calcium-induced cell death (Jacquemyn et al., 2017; Sano and Reed, 2013) . The observed alterations in ER Ca 2+ levels by the LRRK2 G2019S mutation can therefore have a dramatic effect on cell function. Since ER Ca 2+ levels were rescued by a LRRK2-specific ASO, which decreases total LRRK2 protein levels, it is possible that other known LRRK2 mutations could also have an impact on ER calcium control. LRRK2 buffering upon Serca inhibition and KCl depolarization (2, see Figure 3 ), decreased ER Ca 2+ levels (3, see Figure 4 ), and decreased mRNA expression of key storeoperated Ca 2+ entry (SOCE) regulators (4, STIM1, ORAI1, TRPC1, see Table 1 ). Based on these data we hypothesize that LRRK2 plays a role in ER Ca 2+ control, and the G2019S mutation, reported previously to increase the LRRK2 kinase activity (Islam and Moore, 2017; West et al., 2005) , alters calcium homeostasis (Figures 3 and 4) , consequently predisposing neurons carrying this mutation to an increased vulnerability of additional external ER stressors, observed here through an increased neurite collapse upon Serca inhibition (Figure 2) protein colocalizes with the ER in the human brain (Vitte et al., 2010) and is linked with the regulation of a major ER quality control protein chaperone, BiP (Yuan et al., 2011) , suggesting a functional link between the ER and LRRK2. The ER network extends throughout the cell, including the most distal structures, such as axons and dendrites in neurons. Apart from the ER membrane being connected to membranes of the secretory and endocytic pathway via vesicular pathways, ER is functionally connected to multiple organelles such as mitochondria, lysosomes, plasma membrane, multivesicular bodies, and endocytic vesicles via direct ER membrane contact sites (MCSs), sites for intracellular Ca 2+ flux and lipid exchange (Saheki and De Camilli, 2017; Wu et al., 2017) . ER Ca 2+ can be translocated to lysosomes and mitochondria, regulating organelle communication and function (Lam and Galione, 2013 Krols et al., 2016; Lam and Galione, 2013) . Mitochondria also play a significant role in intracellular Ca 2+ store (Lam and Galione, 2013 Cherra et al., 2013; Gomez-Suaga et al., 2012; Guzman et al., 2010; Kilpatrick et al., 2016; Verma et al., 2017) . These results point to an involvement of ER calcium control in the pathogenesis of PD, which is supported by our current findings on LRRK2 function and earlier findings of PARK14 (Zhou et al., 2016) and GBA1 (Kilpatrick et al., 2016; Schondorf et al., 2014) involvement in ER Ca 2+ signaling.
ER receptor IP3R-and RyR-induced calcium release has been shown to be related to synaptic strength (Chakroborty et al., 2012; Deller et al., 2003) . In the context of PD and calcium homeostasis in DA neuron function, this could be important as intracellular Ca 2+ binding to the a-synuclein C terminus influences the strength of a-synuclein lipid membrane binding capacity, thereby modulating synaptic vesicle interactions (Lautenschlager et al., 2018) . Such lipid-vesicle deposition of a-synuclein and p-Tau was recently shown to be altered in aging, the largest risk factor in PD (Brekk et al., 2018) . LRRK2 G2019S-dependent changes in ER calcium control may therefore directly influence a-synuclein synaptic vesicle interaction and docking, a major role of a-synuclein in neuronal synaptic terminals (Logan et al., 2017) . In conclusion, the LRRK2-dependent interactions with ER-dependent calcium homeostasis could be critical for PD pathogenesis.
EXPERIMENTAL PROCEDURES
iPSC Culture and Neuronal Differentiation iPSCs were generated from PD patients carrying the LRRK2 G20919S mutation and HS controls (Cooper et al., 2012; Reinhardt et al., 2013) or were gene corrected using zinc finger nuclease technology as described in Reinhardt et al. (2013) (Table S1) .
To obtain a broad range of human neuronal populations we differentiated iPSCs using a 35 day neuron differentiation protocol modified from Brennand et al. (2011) , generating a mixture of glutamatergic, GABAergic, and dopaminergic neuronal subtypes. Midbrain DA neurons were differentiated using a protocol adapted from Cooper et al. (2010) and Sundberg et al. (2013) and shortened to 28 days.
LRRK2-Specific Antisense Oligomer Treatment, LRRK2 Exon Skipping Analysis, and LRRK2 Protein Expression Analysis
To demonstrate the specific LRRK2 G2019S mutation effect on our cellular phenotypes, a LRRK2 exon 41 antisense phosphorodiamidate morpholino oligomer (ex41 ASO) sequence was developed: 5 0 -AGACAGACCTGATCACCTACCTGGT-3 0 , binding to the premRNA exon 41 sequence and inducing exon 41 skipping. As a control, a non-target standard control sequence (Ctrl ASO) was used: 5 0 -CCTCTTACCTCAGTTACAATTTATA-3 0 (Gene Tools). In addition, ASOs with a carboxyfluorescein or lissamine tag emitting either green or red fluorescence (524.5 or 593.0 nm, respectively) were used to identify ASO-transduced positive cells. Exon skipping analysis was performed as described in Hinrich et al. (2016) . Immunohistochemistry and western blot analysis for LRRK2 human protein detection (UDD3, MRC, University of Dundee) was performed on ASO-transfected iPSC-derived neurons 7 days post plating.
Neurite Outgrowth
Live-cell imaging, using the IncuCyte ZOOM live imaging system (Essen BioScience), was started immediately after plating in 96 well plate format. Seven days post plating, neurons were exposed to THP (Sigma T9033) at 0, 1, 10, and 100 nM concentrations. Neurite length per cell body cluster was measured using the Essen BioScience neurite analysis tool.
To evaluate ex41 ASO-induced rescue on neurite length, the IncuCyte ZOOM images of only ASO-carboxyfluorescein-positive neurons were manually traced in Fiji using the ImageJ NeuronJ plugin. Total neurite length was corrected for the number of ASO+ neurons. 
ER Ca 2+ Live-Cell Imaging
To measure ER Ca 2+ levels, a synapsin promotor-driven Ca 2+ -measuring organelle-entrapped GFP ER indicator (CEPIA-ER GFP; Suzuki et al., 2014) was delivered to ASO-lissamine tag-transfected iPSC-derived neurons using a lentivirus. At day 8 post plating, neurons were imaged at 525 nm in SES for 1 min, followed by 15 s 50 mM KCl treatment and a 1 min wash with SES. Fiji ImageJ software with a Time Series Analyzer v.3 plugin was used to measure GFP levels in each ROI. ASO-lissamine tag-positive, GFP bleached-corrected, and lentivirus transduction efficiency-corrected cells, with a minimum of 2% decrease in GFP levels during KCl stimulation from their own baseline, were included in further analyses. Baseline ER Ca 2+ levels were measured by averaging CEPIA-ER GFP intensity of each line in the first 15-55 s of imaging, prior to the KCl depolarization. ER CICR was measured by correcting the CEPIA-ER GFP fluorescence intensity at the maximum KClstimulated decrease to baseline levels, as described above.
qPCR Analysis of ER Ca 2+ Regulators RNA was isolated and purified according to the RNeasy spin column method (Qiagen, 74104) and cDNA was synthesized using the QuantiTect reverse transcription procedure (Qiagen, 205311) . qPCR was run using the QuantiTect primer assays (Qiagen ,  Table S2 ), using a StepOnePlus real-time PCR system (Applied Biosystems) with a SybrGreen detection method (Applied Biosystems, 4367659). Sample cycle threshold values were normalized to the primer efficiency and to GAPDH housekeeping gene expression levels.
Statistical Analysis
Data analysis was performed in the GraphPad Prism software v.7.0c. All data are expressed as the mean ± SEM. Data were analyzed for normal distribution using the 
